YONGHE MED.GR.DL-0000025 (L97) — Working Capital to Net Assets Ratio
YONGHE MED.GR.DL-0000025 (L97) has a Working Capital to Net Assets ratio of 38.6% as of December 2025. Working capital of €304.20 Million (current assets of €853.50 Million minus current liabilities of €549.30 Million) is measured against net assets of €787.37 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See L97 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
YONGHE MED.GR.DL-0000025 Working Capital to Net Assets (2021–2025)
This chart shows how YONGHE MED.GR.DL-0000025's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 38.6%, reflecting working capital of €304.20 Million against net assets of €787.37 Million EUR. For the complete balance sheet picture, see L97 asset base.
Annual Working Capital to Net Assets for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for YONGHE MED.GR.DL-0000025 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check YONGHE MED.GR.DL-0000025 (L97) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.6% | €304.20 Million | €787.37 Million | €853.50 Million | €549.30 Million | ▲ +26.9 pp |
| 2024 | 11.8% | €84.10 Million | €713.80 Million | €629.82 Million | €545.71 Million | ▲ +2.6 pp |
| 2023 | 9.2% | €86.42 Million | €942.25 Million | €809.33 Million | €722.90 Million | ▼ -34.4 pp |
| 2022 | 43.6% | €690.97 Million | €1.59 Billion | €1.19 Billion | €498.51 Million | ▼ -15.9 pp |
| 2021 | 59.5% | €1.01 Billion | €1.70 Billion | €1.75 Billion | €737.68 Million | — |